The difference between Erexib Tablets and Diclofenac Sodium Extended-Release Tablets mainly lies in the indications, pharmacological effects, adverse reactions and contraindications.
Erythroxib Tablets and Diclofenac Sodium Extended-Release Tablets are non-steroidal anti-inflammatory drugs, with anti-inflammatory and analgesic effects.
1. Indications: Erythroxib Tablets are mainly used to relieve the pain symptoms caused by osteoarthritis. Diclofenac sodium extended-release tablets, on the other hand, have more indications, which can relieve the pain symptoms caused by various chronic arthritis, various soft tissue rheumatic pain and acute mild to moderate pain.
2. Pharmacological effects: Erythroxib tablets mainly through the inhibition of cyclooxygenase to achieve analgesia, while diclofenac sodium extended-release tablets can inhibit the activity of the cyclooxygenase enzyme, blocking the conversion of arachidonic acid to prostaglandins, but also indirectly inhibit the synthesis of leukotrienes.
3. Adverse reactions: Erythroxib tablets common adverse reactions include epigastric discomfort, fecal occult blood, alanine aminotransferase elevation. Diclofenac sodium extended-release tablets can cause nausea and vomiting, diarrhea, tongue inflammation, headache, dizziness, skin rash, serum aminotransferase increased adverse reactions.
4. Contraindications: the main difference between the contraindications of the two drugs is that Erythroxib tablets are not applicable to other Xibu drugs and sulfonamides allergy. Diclofenac sodium extended-release tablets are contraindicated in patients with known hypersensitivity to the product and in patients with asthma, urticaria or allergic reactions induced by taking aspirin or other non-steroidal anti-inflammatory drugs.
It is recommended to apply Erythroxib Tablets or Diclofenac Sodium Extended-Release Tablets under medical supervision.